Resistant Hypertension: Diagnosis, Evaluation, and Treatment

Resistant hypertension is a common clinical problem faced by both primary care clinicians and specialists. While the exact prevalence of resistant hypertension is unknown, clinical trials suggest that it is not rare, involving perhaps 20% to 30% of study participants. As older age and obesity are 2 of the strongest risk factors for uncontrolled hypertension, the incidence of resistant hypertension will likely increase as the population becomes more elderly and heavier. The prognosis of resistant hypertension is unknown, but cardiovascular risk is undoubtedly increased as patients often have a history of long-standing, severe hypertension complicated by multiple other cardiovascular risk factors such as…

• AH
  American Heart Association
• BS
  Bristol-Myers Squibb
• P
  Pfizer
• A
  AstraZeneca
• TJ
  Thomas Jefferson University
• NI
  National Institutes of Health
• HS
  Health Science Center, University of Tennessee
• NH
  National Heart, Lung, and Blood Institute